CVS Health Corporation
CVS
NYSE
$92.86
-$1.16-1.23%
Volume4,030,337
05/19/2022 2:24PM Eastern
Quotes delayed
| Weiss Ratings | CVS - NYSE | - | Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Excellent | -- | ||
| Risk Index | Fair | -- | ||
| Risk Grade | C+ | -- | ||
| Reward Grade | A- | -- | ||
| Rating Factors | CVS - NYSE | - | Click to Compare |
Click to Compare |
| Dividend Index | Fair | -- | ||
| Growth Index | Excellent | -- | ||
| Efficiency Index | Excellent | -- | ||
| Solvency Index | Good | -- | ||
| Total Return Index | Fair | -- | ||
| Volatility Index | Fair | -- | ||
| Beta / Standard Deviation | CVS - NYSE | - | Click to Compare |
Click to Compare |
| Beta | 0.69 | -- | ||
| Price History | CVS - NYSE | - | Click to Compare |
Click to Compare |
| 7-Day Total Return | -4.22% | -- | ||
| 30-Day Total Return | -7.92% | -- | ||
| 60-Day Total Return | -8.08% | -- | ||
| 90-Day Total Return | -10.62% | -- | ||
| Year to Date Total Return | -9.84% | -- | ||
| 1-Year Total Return | 5.51% | -- | ||
| 2-Year Total Return | 50.35% | -- | ||
| 3-Year Total Return | 84.12% | -- | ||
| 5-Year Total Return | 26.72% | -- | ||
| 52-Week High % Change | -15.49% | -- | ||
| 52-Week Low % Change | 18.51% | -- | ||
| Price | CVS - NYSE | - | Click to Compare |
Click to Compare |
| 52-Week High Price | $111.25 | -- | ||
| 52-Week Low Price | $79.34 | -- | ||
| 52-Week Low Price (Date) | Aug 05, 2021 | -- | ||
| 52-Week High Price (Date) | Feb 08, 2022 | -- | ||
| Valuation | CVS - NYSE | - | Click to Compare |
Click to Compare |
| Market Cap | $123.29B | -- | ||
| Enterprise Value | 188.17B | -- | ||
| Price/Earnings (TTM) | 15.63 | -- | ||
| Earnings Per Share (TTM) | 6.02 | -- | ||
| Earnings Per Share Growth | 7.18% | -- | ||
| Price/Earnings To Growth | 2.18 | -- | ||
| Price/Sales (TTM) | 0.42 | -- | ||
| Price/Book (Q) | 1.66 | -- | ||
| Enterprise Value/Revenue (TTM) | 0.63 | -- | ||
| Price | $94.02 | -- | ||
| Enterprise Value/EBITDA (TTM) | 10.06 | -- | ||
| Enterprise Value/EBIT | 13.19 | -- | ||
| Market Cap Category | Large Cap | -- | ||
| Dividends and Shares | CVS - NYSE | - | Click to Compare |
Click to Compare |
| Shares Outstanding | 1.328B | -- | ||
| Dividend Yield | 2.23% | -- | ||
| Div. Per Share (Most Recent) | $0.55 | -- | ||
| Dividend Per Share (TTM) | $2.10 | -- | ||
| Payout Ratio (TTM) | 33.64% | -- | ||
| Dividend Per Share (Most Recent) | $0.55 | -- | ||
| Company Info | CVS - NYSE | - | Click to Compare |
Click to Compare |
| Phone Number | 401-765-1500 | -- | ||
| Address | One CVS Drive Woonsocket, RI 02895 | -- | ||
| Website | www.cvshealth.com | -- | ||
| Country | United States | -- | ||
| Year Founded | 1963 | -- | ||
| Profitability | CVS - NYSE | - | Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 4.77% | -- | ||
| Profit Margin | 2.67% | -- | ||
| Management Effectiveness | CVS - NYSE | - | Click to Compare |
Click to Compare |
| Return on Assets | 3.85% | -- | ||
| Return on Equity | 10.99% | -- | ||
| Income Statement | CVS - NYSE | - | Click to Compare |
Click to Compare |
| Revenue (TTM) | $298.77B | -- | ||
| Total Revenue (TTM) | $298.77B | -- | ||
| Revenue Per Share | $224.98 | -- | ||
| Gross Profit (TTM) | $51.85B | -- | ||
| EBITDA (TTM) | $18.70B | -- | ||
| EBIT (TTM) | $14.26B | -- | ||
| Net Income (TTM) | $8.00B | -- | ||
| Net Income Avl. to Common (TTM) | $8.00B | -- | ||
| Total Revenue Growth (Q YOY) | 11.42% | -- | ||
| Earnings Growth (Q YOY) | 4.00% | -- | ||
| EPS Diluted (TTM) | $6.02 | -- | ||
| EPS Diluted Growth (Q YOY) | 3.57% | -- | ||
| Balance Sheet | CVS - NYSE | - | Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | $11.34B | -- | ||
| Cash Per Share (Q) | $8.54 | -- | ||
| Total Current Assets (Q) | $61.48B | -- | ||
| Total Preferred Equity (Q) | -- | -- | ||
| Total Equity (Q) | $74.14B | -- | ||
| Current Ratio (Q) | 0.881 | -- | ||
| Book Value Per Share (Q) | $56.53 | -- | ||
| Total Assets (Q) | $232.87B | -- | ||
| Total Current Liabilities (Q) | $69.78B | -- | ||
| Total Debt (Q) | $75.92B | -- | ||
| Total Liabilities (Q) | $158.73B | -- | ||
| Total Common Equity (Q) | $73.83B | -- | ||
| Cash Flow | CVS - NYSE | - | Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -$5.39B | -- | ||
| Cash from Financing (TTM) | -$10.76B | -- | ||
| Net Change in Cash (TTM) | $2.79B | -- | ||
| Levered Free Cash Flow (TTM) | $14.18B | -- | ||
| Cash from Operations (TTM) | $18.94B | -- | ||
